IBDEI09D ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3840,2)
 ;;=^5007558
 ;;^UTILITY(U,$J,358.3,3841,0)
 ;;=I69.933^^28^259^35
 ;;^UTILITY(U,$J,358.3,3841,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3841,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Rt Upper Nondominant Side
 ;;^UTILITY(U,$J,358.3,3841,1,4,0)
 ;;=4^I69.933
 ;;^UTILITY(U,$J,358.3,3841,2)
 ;;=^5007559
 ;;^UTILITY(U,$J,358.3,3842,0)
 ;;=I69.998^^28^259^42
 ;;^UTILITY(U,$J,358.3,3842,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3842,1,3,0)
 ;;=3^Cerebrovascular Disease,Sequelae,Unspec
 ;;^UTILITY(U,$J,358.3,3842,1,4,0)
 ;;=4^I69.998
 ;;^UTILITY(U,$J,358.3,3842,2)
 ;;=^5007572
 ;;^UTILITY(U,$J,358.3,3843,0)
 ;;=I69.928^^28^259^43
 ;;^UTILITY(U,$J,358.3,3843,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3843,1,3,0)
 ;;=3^Cerebrovascular Disease,Speech/Language Deficits,Unspec
 ;;^UTILITY(U,$J,358.3,3843,1,4,0)
 ;;=4^I69.928
 ;;^UTILITY(U,$J,358.3,3843,2)
 ;;=^5007557
 ;;^UTILITY(U,$J,358.3,3844,0)
 ;;=I69.965^^28^259^37
 ;;^UTILITY(U,$J,358.3,3844,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3844,1,3,0)
 ;;=3^Cerebrovascular Disease,Paralytic Syndrome,Bilateral,Unspec
 ;;^UTILITY(U,$J,358.3,3844,1,4,0)
 ;;=4^I69.965
 ;;^UTILITY(U,$J,358.3,3844,2)
 ;;=^5007566
 ;;^UTILITY(U,$J,358.3,3845,0)
 ;;=I69.962^^28^259^38
 ;;^UTILITY(U,$J,358.3,3845,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3845,1,3,0)
 ;;=3^Cerebrovascular Disease,Paralytic Syndrome,Lt Dominant Side
 ;;^UTILITY(U,$J,358.3,3845,1,4,0)
 ;;=4^I69.962
 ;;^UTILITY(U,$J,358.3,3845,2)
 ;;=^5133588
 ;;^UTILITY(U,$J,358.3,3846,0)
 ;;=I69.964^^28^259^39
 ;;^UTILITY(U,$J,358.3,3846,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3846,1,3,0)
 ;;=3^Cerebrovascular Disease,Paralytic Syndrome,Lt Nondominant Side
 ;;^UTILITY(U,$J,358.3,3846,1,4,0)
 ;;=4^I69.964
 ;;^UTILITY(U,$J,358.3,3846,2)
 ;;=^5133589
 ;;^UTILITY(U,$J,358.3,3847,0)
 ;;=I69.961^^28^259^40
 ;;^UTILITY(U,$J,358.3,3847,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3847,1,3,0)
 ;;=3^Cerebrovascular Disease,Paralytic Syndrome,Rt Dominant Side
 ;;^UTILITY(U,$J,358.3,3847,1,4,0)
 ;;=4^I69.961
 ;;^UTILITY(U,$J,358.3,3847,2)
 ;;=^5007564
 ;;^UTILITY(U,$J,358.3,3848,0)
 ;;=I69.963^^28^259^41
 ;;^UTILITY(U,$J,358.3,3848,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3848,1,3,0)
 ;;=3^Cerebrovascular Disease,Paralytic Syndrome,Rt Nondominant Side
 ;;^UTILITY(U,$J,358.3,3848,1,4,0)
 ;;=4^I69.963
 ;;^UTILITY(U,$J,358.3,3848,2)
 ;;=^5007565
 ;;^UTILITY(U,$J,358.3,3849,0)
 ;;=G90.50^^28^259^44
 ;;^UTILITY(U,$J,358.3,3849,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3849,1,3,0)
 ;;=3^Complex Regional Pain Syndrome I,Unspec
 ;;^UTILITY(U,$J,358.3,3849,1,4,0)
 ;;=4^G90.50
 ;;^UTILITY(U,$J,358.3,3849,2)
 ;;=^5004163
 ;;^UTILITY(U,$J,358.3,3850,0)
 ;;=R56.9^^28^259^45
 ;;^UTILITY(U,$J,358.3,3850,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3850,1,3,0)
 ;;=3^Convulsions,Unspec
 ;;^UTILITY(U,$J,358.3,3850,1,4,0)
 ;;=4^R56.9
 ;;^UTILITY(U,$J,358.3,3850,2)
 ;;=^5019524
 ;;^UTILITY(U,$J,358.3,3851,0)
 ;;=G37.9^^28^259^46
 ;;^UTILITY(U,$J,358.3,3851,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3851,1,3,0)
 ;;=3^Demyelinating Disease of Central Nervous System,Unspec
 ;;^UTILITY(U,$J,358.3,3851,1,4,0)
 ;;=4^G37.9
 ;;^UTILITY(U,$J,358.3,3851,2)
 ;;=^5003828
 ;;^UTILITY(U,$J,358.3,3852,0)
 ;;=G36.9^^28^259^47
 ;;^UTILITY(U,$J,358.3,3852,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3852,1,3,0)
 ;;=3^Demyelination,Disseminated,Acute,Unspec
 ;;^UTILITY(U,$J,358.3,3852,1,4,0)
 ;;=4^G36.9
 ;;^UTILITY(U,$J,358.3,3852,2)
 ;;=^5003820
 ;;^UTILITY(U,$J,358.3,3853,0)
 ;;=R42.^^28^259^48
